# Developmental Funds

> **NIH NIH P30** · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · 2024 · $238,278

## Abstract

DEVELOPMENTAL FUNDS: ABSTRACT
Developmental funds from a variety of sources (e.g., CCSG, other sponsored research, institution, state,
philanthropy, etc.) enable the Stephenson Cancer Center (SCC) to pursue new research innovation and
collaboration. They help advance the SCC’s overall mission and strategic goals as well as provide support for
program leaders to achieve targeted scientific goals. Essential activities supported by developmental funds
include: intramural grant programs, recruitment of new investigators, career development for early-stage
investigators, and new shared resource development. These help advance the SCC’s core strategic priorities:
1) enhancing breadth, depth and impact of cancer-focused research; 2) fostering the translation of discoveries
into the clinical or community setting; 3) designing and conducting hypothesis-driven trials to improve
outcomes for people with or at risk for cancer; 4) promoting intra- and inter-programmatic collaboration and
transdisciplinary team science; 5) enhancing COE to address priority cancers and cancer problems prevalent
in the SCC catchment area; 6) increasing training and mentorship opportunities for students and faculty; and 7)
enhancing the presence of underrepresented minority (URM) persons and women among SCC leadership and
membership, and in pipeline programs. All decisions concerning the allocation of developmental funds
ultimately rest with the SCC director, who meets with the center’s research leadership team biweekly to
discuss new research opportunities and allocation of developmental funds in the form of intramural grants,
recruitment, investments in new technologies, and targeted funding to pursue new strategically driven
initiatives.
The SCC has utilized developmental funds awarded through intramural grant programs to stimulate new
research, enhance transdisciplinary collaboration, support career development, and address priority cancers
and cancer problems prevalent in the SCC catchment area. During the reporting period (CY2017-21), the SCC
awarded 85 intramural grants through a variety of programs, with a total award amount of $3,053,349. As of
12/31/21, these grants have resulted in 71 peer-reviewed publications and $10,246,254 (total, direct cost) in
extramural sponsored research funding. Notably, 21 of these 85 were awarded through grant programs newly
established since 2020; thus, they are just completing first funding cycles and are still pending outcomes. In
addition, developmental funds have been used to recruit 31 new cancer-focused investigators to the SCC (both
the OUHSC and OU Norman campuses) over the past five years, significantly enhancing transdisciplinary
expertise and the potential for team science among the SCC’s three programs. Notably, five (16%) of these
new recruits are URM individuals and more than half (n=16) are female.

## Key facts

- **NIH application ID:** 10838565
- **Project number:** 5P30CA225520-07
- **Recipient organization:** UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
- **Principal Investigator:** ROBERT S. MANNEL
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $238,278
- **Award type:** 5
- **Project period:** 2018-05-01 → 2028-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10838565

## Citation

> US National Institutes of Health, RePORTER application 10838565, Developmental Funds (5P30CA225520-07). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10838565. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*